Silencing of miR-193a-5p increases the chemosensitivity of prostate cancer cells to docetaxel
- PMID: 29216925
- PMCID: PMC5721613
- DOI: 10.1186/s13046-017-0649-3
Silencing of miR-193a-5p increases the chemosensitivity of prostate cancer cells to docetaxel
Abstract
Background: Docetaxel-based chemotherapy failure in advanced prostate carcinoma has partly been attributed to the resistance of prostate cancer (PC) cells to docetaxel-induced apoptosis. Hence, there is an urgent need to identify mechanisms of docetaxel chemoresistance and to develop new combination therapies.
Methods: miR-193a-5p level was evaluated by qPCR in prostate tissues and cell lines, and its expression in the tissues was also examined by in situ hybridization. PC cell line (PC3 cell) was transfected with miR-193a-5p mimic or its inhibitor, and then cell apoptosis and the expression of its downstream genes Bach2 and HO-1 were detected by TUNEL staining and Western blotting. Luciferase reporter assay was used to detect the effect of miR-193a-5p and Bach2 on HO-1 expression. Xenograft animal model was used to test the effect of miR-193a-5p and docetaxel on PC3 xenograft growth.
Results: miR-193a-5p was upregulated in PC tissues and PC cell lines, with significant suppression of PC3 cell apoptosis induced by oxidative stress. Mechanistically, miR-193a-5p suppressed the expression of Bach2, a repressor of the HO-1 gene, by directly targeting the Bach2 mRNA 3'-UTR. Docetaxel treatment modestly decreased Bach2 expression and increased HO-1 level in PC3 cells, whereas a modest increase of HO-1 facilitated docetaxel-induced apoptosis. Notably, docetaxel-induced miR-193a-5p upregulation, which in turn inhibits Bach2 expression and thus relieves Bach2 repression of HO-1 expression, partly counteracted docetaxel-induced apoptosis, as evidenced by the increased Bcl-2 and decreased Bax expression. Accordingly, silencing of miR-193a-5p enhanced sensitization of PC3 cells to docetaxel-induced apoptosis. Finally, depletion of miR-193a-5p significantly reduced PC xenograft growth in vivo.
Conclusions: Silencing of miR-193a-5p or blockade of the miR-193a-5p-Bach2-HO-1 pathway may be a novel therapeutic approach for castration-resistant PC.
Keywords: Bach2; Chemoresistance; Docetaxel; HO-1; Prostate cancer; miR-193a-5p.
Conflict of interest statement
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures
Similar articles
-
Long noncoding RNA LINC01234 silencing exerts an anti-oncogenic effect in esophageal cancer cells through microRNA-193a-5p-mediated CCNE1 downregulation.Cell Oncol (Dordr). 2020 Jun;43(3):377-394. doi: 10.1007/s13402-019-00493-5. Epub 2020 Mar 4. Cell Oncol (Dordr). 2020. PMID: 32130660
-
Long non-coding RNA TTN-AS1 promotes cell proliferation and inhibits cell apoptosis in prostatic cancer by sponging miR-193a-5p.Eur Rev Med Pharmacol Sci. 2019 Sep;23(18):7816-7825. doi: 10.26355/eurrev_201909_18991. Eur Rev Med Pharmacol Sci. 2019. PMID: 31599406
-
miR-375 induces docetaxel resistance in prostate cancer by targeting SEC23A and YAP1.Mol Cancer. 2016 Nov 10;15(1):70. doi: 10.1186/s12943-016-0556-9. Mol Cancer. 2016. PMID: 27832783 Free PMC article.
-
Role of miR-193a in Cancer: Complexity and Factors Control the Pattern of its Expression.Curr Cancer Drug Targets. 2018;18(7):618-628. doi: 10.2174/1568009618666180308105727. Curr Cancer Drug Targets. 2018. PMID: 29521232 Review.
-
Role of microRNAs in the resistance of prostate cancer to docetaxel and paclitaxel.Contemp Oncol (Pozn). 2015;19(6):423-7. doi: 10.5114/wo.2015.56648. Epub 2016 Jan 13. Contemp Oncol (Pozn). 2015. PMID: 26843836 Free PMC article. Review.
Cited by
-
Early to sustained impacts of lethal radiation on circulating miRNAs in a minipig model.Sci Rep. 2023 Oct 28;13(1):18496. doi: 10.1038/s41598-023-45250-9. Sci Rep. 2023. PMID: 37898651 Free PMC article.
-
RBM25 induces trophoblast epithelial-mesenchymal transition and preeclampsia disorder by enhancing the positive feedback loop between Grhl2 and RBM25.Exp Biol Med (Maywood). 2023 Jul;248(14):1267-1277. doi: 10.1177/15353702231191199. Epub 2023 Sep 20. Exp Biol Med (Maywood). 2023. PMID: 37728157
-
Four differentially expressed exosomal miRNAs as prognostic biomarkers and therapy targets in endometrial cancer: Bioinformatic analysis.Medicine (Baltimore). 2023 Aug 25;102(34):e34998. doi: 10.1097/MD.0000000000034998. Medicine (Baltimore). 2023. PMID: 37653757 Free PMC article.
-
Cytoprotective Role of Heme Oxygenase-1 in Cancer Chemoresistance: Focus on Antioxidant, Antiapoptotic, and Pro-Autophagy Properties.Antioxidants (Basel). 2023 Jun 5;12(6):1217. doi: 10.3390/antiox12061217. Antioxidants (Basel). 2023. PMID: 37371947 Free PMC article. Review.
-
Pharmacological Significance of Heme Oxygenase 1 in Prostate Cancer.Curr Issues Mol Biol. 2023 May 15;45(5):4301-4316. doi: 10.3390/cimb45050273. Curr Issues Mol Biol. 2023. PMID: 37232742 Free PMC article. Review.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
